Answer
Pegcetacoplan may interfere with silica reagents in coagulation panels, causing artificially prolonged activated partial thromboplastin time (aPTT), so silica reagents should be avoided.
Sources for this answer
- ASPAVELI 1080 mg solution for infusionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 9Document updated
Sources checked